QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

Pharmaceutical compositions for oral administration comprising a compound of formula (lb) or (Ic) or an enantiomer, diastereomer, tautomer, or salt thereof, and a pharmaceutically acceptable vehicle or diluent:wherein X, Y, Z, R13a - d, R13a-2-d-2and R25are described herein. The compounds are useful...

Full description

Saved in:
Bibliographic Details
Main Authors NEELS, James, LLOYD, John, BANERJEE, Abhisek, JOHNSON, James A, DHONDI, Naveen Kumar, JIANG, Ji, GUNAGA, Prashantha, ADISECHAN, Ashok Kumar, FINLAY, Heather
Format Patent
LanguageEnglish
French
German
Published 27.10.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Pharmaceutical compositions for oral administration comprising a compound of formula (lb) or (Ic) or an enantiomer, diastereomer, tautomer, or salt thereof, and a pharmaceutically acceptable vehicle or diluent:wherein X, Y, Z, R13a - d, R13a-2-d-2and R25are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
AbstractList Pharmaceutical compositions for oral administration comprising a compound of formula (lb) or (Ic) or an enantiomer, diastereomer, tautomer, or salt thereof, and a pharmaceutically acceptable vehicle or diluent:wherein X, Y, Z, R13a - d, R13a-2-d-2and R25are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Author GUNAGA, Prashantha
LLOYD, John
JIANG, Ji
FINLAY, Heather
NEELS, James
DHONDI, Naveen Kumar
JOHNSON, James A
BANERJEE, Abhisek
ADISECHAN, Ashok Kumar
Author_xml – fullname: NEELS, James
– fullname: LLOYD, John
– fullname: BANERJEE, Abhisek
– fullname: JOHNSON, James A
– fullname: DHONDI, Naveen Kumar
– fullname: JIANG, Ji
– fullname: GUNAGA, Prashantha
– fullname: ADISECHAN, Ashok Kumar
– fullname: FINLAY, Heather
BookMark eNrjYmDJy89L5WQwCAz19HOM8vfx9HMNVnAMVgjwD3EMDvYM9VXw9PdTcPZw9PNz9VHw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxqbmpkYWFk6GxkQoAQD62ygA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate CHINAZOLINE ALS KALIUMIONENKANALHEMMER
QUINAZOLINES EN TANT QU'INHIBITEURS DU CANAL IONIQUE DU POTASSIUM
ExternalDocumentID EP3575288B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3575288B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:19:51 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3575288B13
Notes Application Number: EP20190186129
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211027&DB=EPODOC&CC=EP&NR=3575288B1
ParticipantIDs epo_espacenet_EP3575288B1
PublicationCentury 2000
PublicationDate 20211027
PublicationDateYYYYMMDD 2021-10-27
PublicationDate_xml – month: 10
  year: 2021
  text: 20211027
  day: 27
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Bristol-Myers Squibb Company
RelatedCompanies_xml – name: Bristol-Myers Squibb Company
Score 3.3601096
Snippet Pharmaceutical compositions for oral administration comprising a compound of formula (lb) or (Ic) or an enantiomer, diastereomer, tautomer, or salt thereof,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211027&DB=EPODOC&locale=&CC=EP&NR=3575288B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St-KWpB97GNKv0crW1q2T4ctougb2Moer-O97Kdv0Rd-OBC7JwX38ktwdwIMlC8somNS57HCdL0yqC4uaupBdlpu24N36b84oNsMpf54ZswYsd7kwdZ3Qr7o4ImpUgfpe1fZ6_XOJ5dd_KzePYolD70-DrO9rW3Ss0Ay1NN_tB2niJ57meUhp8bjPMCyhtu0iUDpQUbQqsx-8uiopZf3bowxO4TBFZqvqDBrlqgXH3q7xWguORtv3biS3qrc5h87LNIqdt2So2mQQZ0LSJHPQFE5HBM0h8UInjoMhieIwcqMsGU8ugAyCzAt1XHq-P-Y8SPebZJfQRPRfXgGRTNoGZ6XsyZwzKno9WYq8sKlli4XJ8za0_2Rz_c_cDZwoeSkzTK1baFYfn-Ud-tdK3NeS-QYuLHsr
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8Iw9IWgEW-KGsGvHsxui9CWdRyI2RfZlH0IwxAvZB1rwgWJzPj3bRdAL3p7aZPX15e8r_Z9ANwzkbNeToRORYfqdGFgnTNs6Fx0SWaYnHar3JwwMvwpfZr1ZjVY7mphqj6hX1VzRClRuZT3stLX659HLLfKrdw88KVcen8cpgNX20bHKprBTHPtgZfEbuxojiMhLRoPiHRLsGnaMlA6YKo5r_KcXm1VlLL-bVGGJ3CYSGSr8hRqxaoJDWc3eK0JR-H2v1uCW9HbnEHnZRpE1ls8UmMykDVBSZxaUhVOQyTVIXJ8K4q8EQoiP7CDNB5PzgENvdTxdXn0fH_NuZfsiSQXUJfRf3EJSBBh9igpRF9klGDe74uCZ7mJmckXBs1a0PoTTfufvTto-Gk4mkuqn6_gWPFOqWTMrqFefnwWN9LWlvy24tI3GPl-GA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=QUINAZOLINES+AS+POTASSIUM+ION+CHANNEL+INHIBITORS&rft.inventor=NEELS%2C+James&rft.inventor=LLOYD%2C+John&rft.inventor=BANERJEE%2C+Abhisek&rft.inventor=JOHNSON%2C+James+A&rft.inventor=DHONDI%2C+Naveen+Kumar&rft.inventor=JIANG%2C+Ji&rft.inventor=GUNAGA%2C+Prashantha&rft.inventor=ADISECHAN%2C+Ashok+Kumar&rft.inventor=FINLAY%2C+Heather&rft.date=2021-10-27&rft.externalDBID=B1&rft.externalDocID=EP3575288B1